CirrusDx Acquires Dascena’s Texas Laboratory Business, Expanding Infectious Disease Portfolio
Through the acquisition CirrusDx will enhance its current services by further expanding its national laboratory footprint
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Aug 22
Through the acquisition CirrusDx will enhance its current services by further expanding its national laboratory footprint
03 Aug 22
MDxHealth has acquired Oncotype DX GPS Prostate Cancer Business, along with a team of urology sales and marketing…
03 Aug 22
A combination of FlashPad detectors, advanced image creation applications, and the latest AI-driven Helix Advanced Image Processing software…
03 Aug 22
FDA EUA Variant Calling Assay Allows for Sequencing to Inform Patient Treatment
03 Aug 22
Mira's new Ovum Wand provides lab-accurate detection of the follicle-stimulating hormone (FSH) to predict menopause, evaluate fertility and…
02 Aug 22
The sale, which will include Applied, Food and Enterprise Services businesses, will accelerate the transformation of PerkinElmer into…
02 Aug 22
With Thermo Scientific's Arctis Cryo-Plasma FIB, cellular cryo-electron tomography can be performed quickly and consistently
02 Aug 22
Renegade.bio is accelerating humanity’s capacity to test for infectious diseases in underserved communities
01 Aug 22
Meridian’s molecular diagnostic test is now authorised for the qualitative detection of the SARS-CoV-2 virus, including its Omicron…
01 Aug 22
A jury for the US District Court of Delaware has confirmed the use of Magnolia’s patented Initial Specimen…